Metreleptin in Lipodystrophy: A Profile of Its Use

Drugs and Therapy Perspectives - United Kingdom
doi 10.1007/s40267-019-00622-y
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy

Endocrine Practice
MedicineEndocrinologyMetabolismDiabetes
2011English

Metreleptin-Mediated Improvements in Insulin Sensitivity Are Independent of Food Intake in Humans With Lipodystrophy

Journal of Clinical Investigation
Medicine
2018English

Efficacy and Safety of Metreleptin in Patients With Partial Lipodystrophy: Lessons From an Expanded Access Program

Journal of Diabetes & Metabolism
2016English

Psy11 - Real-World Experience of Generalized Lipodystrophy Patients Enrolled in the Metreleptin Early Access Program: Initial Results

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Afatinib in Advanced NSCLC: A Profile of Its Use

Drugs and Therapy Perspectives
Pharmacology
2018English

Insulin Glargine/Lixisenatide in Type 2 Diabetes: A Profile of Its Use

Drugs and Therapy Perspectives
Pharmacology
2019English

Osimertinib as First-Line Therapy in Advanced NSCLC: A Profile of Its Use

Drugs and Therapy Perspectives
Pharmacology
2018English

Primary Lipodystrophy

2020English

Progressive Lipodystrophy

2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy